technetium has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rycke, R; De Vos, F; Libert, C; Steeland, S; Toussaint, W; Van Imschoot, G; Van Ryckeghem, S; Vandenbroucke, RE; Vanhoutte, L; Vanhove, C | 1 |
| Chandler, N; Connolly, R; Esposito, P; Jacobson, S; Theoharides, TC | 1 |
2 other study(ies) available for technetium and Allergic Encephalomyelitis
| Article | Year |
|---|---|
TNFR1 inhibition with a Nanobody protects against EAE development in mice.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Male; Mice, Transgenic; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Peptide Fragments; Receptors, Tumor Necrosis Factor, Type I; Single-Domain Antibodies; Spinal Cord; Technetium; Tumor Necrosis Factor-alpha; Whole Body Imaging | 2017 |
Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Capillary Permeability; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Female; Incidence; Mice; Mice, Inbred Strains; Stress, Physiological; Technetium; Time Factors | 2002 |